Diabetes risk from statins in schizophrenia: could metformin be the answer?
NCT ID NCT07045142
First seen Jun 24, 2026 · Last updated Aug 04, 2026 · Updated 5 times
Summary
This study tests whether the diabetes drug metformin can prevent blood sugar increases caused by statins in people with schizophrenia. Researchers will give 400 patients either metformin or a placebo alongside atorvastatin for six months. The goal is to see if metformin helps keep glucose levels stable, reducing the risk of diabetes and heart disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Metformin
- What this could lead to
- If it works, this could offer a way to prevent diabetes in schizophrenia patients who need statins for heart health, improving their overall care.
- What could go wrong
- This is a phase 3 trial, but it's still early to know if metformin will work for this specific use. The study focuses on blood sugar markers, not long-term health outcomes, and metformin may cause digestive side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Junshan District Psychiatric Rehabilitation Hospital
ACTIVE_NOT_RECRUITINGYueyang, Hunan, 414000, China
-
Mental Health Institute of Second Xiangya Hospital, CSU
RECRUITINGChangsha, Hunan, China
-
The Second People's Hospital of Dali Bai Autonomous Prefecture
COMPLETEDDali, Yunnan, China
-
The Second People's Hospital of Xiangyin County
ACTIVE_NOT_RECRUITINGYueyang, Hunan, 410500, China
-
The Third Hospital of Changsha County
ACTIVE_NOT_RECRUITINGChangsha, Hunan, China
-
Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals District
ACTIVE_NOT_RECRUITINGXiangshan, Zhejiang, 315799, China
-
Yueyang Rehabilitation Hospital
RECRUITINGYueyang, Hunan, 414022, China
-
Zhumadian Second People's Hospital
ACTIVE_NOT_RECRUITINGZhumadian, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?